Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Jul 16, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Clinical Data Specialist II Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Clinical Data Specialist I Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Business Data Analyst II Hyderabad (Office) India Biomedical Research Data and Digital Sep 11, 2024
BR Submission Management, Lead Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
BR Submission Management, Specialist Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Laboratorijski analitik (m/ž/d) Ljubljana Slovenia Quality Oct 10, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Switzerland Legal Corporate Others Sep 26, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 16, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Jun 20, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Aug 29, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
Associate Director, SUSE Linux Administrator Prague Czech Republic Operations Corporate Technology Transformation Sep 23, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Oct 08, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Oct 14, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Oct 17, 2024
Vice President, Head of R&D Legal, Americas Cambridge (USA) USA Legal Corporate Legal & Intellectual Property & Compl. Oct 17, 2024
Executive Director, R&D Legal and FDA Regulatory Legal Lead East Hanover USA Legal Corporate Legal & Intellectual Property & Compl. Oct 17, 2024
Financial IT Compliance Senior Specialist London (The Westworks) United Kingdom Finance Corporate Audit & Finance Oct 25, 2024
Financial IT Compliance Manager London (The Westworks) United Kingdom Finance Corporate Audit & Finance Oct 25, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Switzerland Corporate Affairs Corporate BD&L & Strategic Planning Oct 15, 2024
BPA Manager - Global Process Owner Hyderabad (Office) India Finance Corporate Audit & Finance Oct 24, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Oct 22, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Oct 22, 2024
Tax Specialist Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 20, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance Aug 29, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 01, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Strategic Design Commercial Contracts Manager Barcelona Gran Vía Spain Operations CTS Marketing Sep 24, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Oct 04, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Oct 22, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia